Non-invasive Intracranial Pressure Monitoring to Improve Emergency Care in Brazil's Public Health System
Evaluation and Enhancement of the Effectiveness of Non-invasive Intracranial Pressure Monitoring for Screening in Neurological Emergencies Within the Brazilian Unified Health System
1 other identifier
observational
300
1 country
3
Brief Summary
The goal of this observational study is to evaluate the diagnostic accuracy of non-invasive intracranial pressure (ICP) and intracranial compliance (ICC) pulse morphology and associated parameters (such as the P2/P1 ratio and nTTP) obtained with the brain4care system for the screening of intracranial hypertension (ICH) in patients with traumatic brain injury (TBI) and stroke treated in Brazil's public health system (SUS). The main questions it aims to answer are: Can non-invasive ICP and ICC pulse morphology reliably identify or exclude intracranial hypertension, cerebral edema, and hemorrhage compared to CT findings and clinical/neurological evaluations? Can this approach differentiate ischemic stroke from hemorrhagic stroke with sufficient accuracy? Does the use of brain4care contribute to earlier detection, improved clinical decision-making, and cost reduction in emergency settings?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 7, 2025
CompletedStudy Start
First participant enrolled
December 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 28, 2028
October 7, 2025
September 1, 2025
2 years
September 30, 2025
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of non-invasive ICP and compliance parameters
Diagnostic accuracy of non-invasive ICP and compliance parameters (P2/P1 ratio, nTTP) obtained with the brain4care system for detecting intracranial hypertension, assessed by sensitivity, specificity, predictive values, and ROC curve analysis, using neuroimaging and clinical evaluation as reference standards.
From enrollment up to 14 days in the intensive care unit.
Secondary Outcomes (1)
Correlation of non-invasive ICP/ICC parameters with clinical and imaging findings in TBI and stroke patients
From enrollment up to 14 days in the intensive care unit.
Other Outcomes (1)
Differentiation of ischemic vs. hemorrhagic stroke
From enrollment up to 14 days in the intensive care unit.
Study Arms (2)
Traumatic Brain Injury
Traumatic Brain Injury
Stroke
Stroke
Interventions
non-invasive intracranial pressure monitoring that provides continuous bedside monitoring.
Eligibility Criteria
Adult patients (≥18 years) of both sexes presenting with clinical signs and symptoms of traumatic brain injury (mild, moderate, or severe) or stroke (ischemic or hemorrhagic). Participants will be recruited from multiple levels of care within the Brazilian Unified Health System (SUS), including primary care units (UBS), urgent care units (UPA), pre-hospital emergency services (SAMU), hospital emergency rooms (PS), and intensive care units (ICUs) at participating hospitals in the states of Amazonas, São Paulo, Sergipe, and Rio Grande do Sul.
You may qualify if:
- Patients of both sexes.
- Age ≥ 18 years.
- Clinical signs and symptoms of traumatic brain injury (mild, moderate, or severe) or stroke (ischemic or hemorrhagic).
- Signed informed consent form by the patient or by a legally authorized representative in cases where the patient is unable to consent due to the severity of the clinical condition. If the legal representative is not present at the time of admission or initial care, consent may be obtained retrospectively.
You may not qualify if:
- Individuals with brain lesions of other etiologies, such as previous TBI and/or stroke, neoplasms, infections, sepsis, arteriovenous malformation, intoxication, or illicit drug use.
- Individuals with scalp or skin lacerations that prevent proper placement of the brain4care sensor.
- Individuals with craniectomy or skull fractures.
- Individuals with severe debilitating mental health disorders and/or severe debilitating neurological diseases.
- Individuals who are agitated, aggressive, or uncooperative, preventing follow-up and outcome assessment.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Braincare USA Corplead
- Universidade Federal de Sergipecollaborator
- Federal University of São Paulocollaborator
- Federal University of Amazonascollaborator
Study Sites (3)
Hospital Universitário Getúlio Vargas
Manaus, Amazonas, 69020-170, Brazil
Hospital Universitário de Lagarto
Lagarto, Sergipe, 49400-000, Brazil
Hospital São Paulo
São Paulo, São Paulo, 04024-002, Brazil
Related Publications (3)
R. d. A. P. Andrade et al., "A Nanometer Resolution Wearable Wireless Medical Device for Non Invasive Intracranial Pressure Monitoring," in IEEE Sensors Journal, vol. 21, no. 20, pp. 22270-22284, 15 Oct.15, 2021, doi: 10.1109/JSEN.2021.3090648
BACKGROUNDGoto Y. [Cardiac energetics and coronary circulation]. Nihon Rinsho. 1994 Jul;52 Suppl(Pt 1):67-77. No abstract available. Japanese.
PMID: 12436508BACKGROUNDOcamoto GN, da Silva LN, da Silva Rocha Tomaz C, Hisatugu MT, Frigieri G, Cardim D, Goncalves RL, Russo TL, de Amorim RLO. Characterization of intracranial compliance in healthy subjects using a noninvasive method - results from a multicenter prospective observational study. J Clin Monit Comput. 2024 Dec;38(6):1249-1261. doi: 10.1007/s10877-024-01191-w. Epub 2024 Jul 20.
PMID: 39031230BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robson L Oliveira de Amorim, PhD
Federal University of Amazonas
- PRINCIPAL INVESTIGATOR
Fabiano Moulin de Moraes, PhD
Federal University of São Paulo
- PRINCIPAL INVESTIGATOR
Rita C Almeida Vieira, PhD
Federal University of Sergipe
- STUDY CHAIR
Gustavo H Frigieri Vilela, PhD
Braincare USA
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 14 Days
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2025
First Posted
October 7, 2025
Study Start
December 16, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
January 28, 2028
Last Updated
October 7, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and regulatory restrictions imposed by local ethics committees and data protection regulations.